Peri‐implantitis‐like medication‐related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning microscope
暂无分享,去创建一个
[1] P. Vescovi,et al. Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020 , 2020, International journal of environmental research and public health.
[2] G. Campisi,et al. Medication-related osteonecrosis of the jaw in a cancer patient receiving lenvatinib. , 2019, International journal of oral and maxillofacial surgery.
[3] G. Huynh-Ba,et al. Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. , 2018, Journal of clinical periodontology.
[4] G. Huynh-Ba,et al. Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. , 2018, Journal of clinical periodontology.
[5] E. Maiorano,et al. A Case of Osteonecrosis of the Jaw in a Patient with Crohn’s Disease Treated with Infliximab , 2017, The American journal of case reports.
[6] F. Mazzoni,et al. Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect. , 2017, Current medicinal chemistry.
[7] M. Ehrenfeld,et al. Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis? , 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[8] E. Maiorano,et al. Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience , 2016, International journal of dentistry.
[9] A. Polimeni,et al. Adalimumab: Another Medication Related to Osteonecrosis of the Jaws? , 2016, Case reports in dentistry.
[10] T. Dodson,et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. , 2014, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[11] A. Santarelli,et al. Osteopontin, osteocalcin and OB-cadherin expression in Synthetic nanohydroxyapatite vs bovine hydroxyapatite cultured Osteoblastic-like cells. , 2014, Journal of biological regulators and homeostatic agents.
[12] E. Maiorano,et al. New Dimensional Staging of Bisphosphonate-Related Osteonecrosis of the Jaw Allowing a Guided Surgical Treatment Protocol: Long-Term Follow-Up of 266 Lesions in Neoplastic and Osteoporotic Patients from the University of Bari , 2014, International journal of dentistry.
[13] So-Young Choi,et al. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. , 2014, Clinical oral implants research.
[14] K. Grätz,et al. Osteopathology induced by bisphosphonates and dental implants: clinical observations , 2012, Clinical Oral Investigations.
[15] A. Piattelli,et al. Osteonecrosis of the posterior mandible after implant insertion: a clinical and histological case report. , 2011, Clinical implant dentistry and related research.
[16] P. Nocini,et al. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review. , 2010, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[17] S. Koka,et al. Survival of dental implants in post-menopausal bisphosphonate users. , 2010, Journal of prosthodontic research.
[18] N. Yarom,et al. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. , 2010, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[19] A. Goss,et al. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series. , 2010, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[20] E. Maiorano,et al. Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy. , 2009, Bone.
[21] L. Assael,et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. , 2009, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[22] R. E. Bell,et al. Oral bisphosphonates and dental implants: a retrospective study. , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[23] R. Kraut,et al. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[24] S. Drew,et al. Osteonecrosis of the Jaws and Bisphosphonate Therapy , 2007, Journal of dental research.
[25] G. Sándor,et al. A review of bisphosphonate-associated osteonecrosis of the jaws and its management. , 2007, Journal.
[26] C. Scully,et al. Dental Endosseous Implants in Patients on Bisphosphonate Therapy , 2006, Implant dentistry.
[27] R. Marx. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. , 2003, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.